Avalon GloboCare Corp. is a commercial-stage company focused on developing and delivering precision diagnostic consumer products, advancing cellular therapy intellectual property, and owning commercial real estate properties in the United States. It markets the KetoAir™ breathalyzer, a handheld nanosensor device that measures breath acetone levels to monitor ketosis and fat metabolism, integrated into wellness programs for first responders and ketogenic health management. The company distributes KetoAir™ through wholesale agreements, affiliate programs, and online channels in the United States and United Kingdom, while co-developing additional applications like a cannabis breathalyzer for point-of-care detection. Avalon GloboCare Corp. advances proprietary CAR-T and CAR-NK cell technologies, including bispecific designs and cytokine induction methods protected by patents in multiple jurisdictions. Through subsidiaries like Avalon Quantum AI, LLC and Q&A Distribution, LLC, it operates generative AI software for nutrition and publishing, alongside real estate operations. Founded in 2015 and headquartered in Freehold, New Jersey, Avalon GloboCare Corp. plays a role in the intersection of diagnostics, biotech IP, AI-enabled health tools, and property management within healthcare and real estate markets.
Website4400 Route 9 South
Freehold, NJ, 07728
United States
Detailed price information for Avalon Globocare (ALBT-Q) from The Globe and Mail including charting and trades.
Tipranks Press Release.
Detailed price information for Avalon Globocare (ALBT-Q) from The Globe and Mail including charting and trades.
Avalon GloboCare Corp. (NASDAQ:ALBT) said Monday it is rebranding as Change Agents Corp. as it completes its transition into a pure-play agentic artificial intelligence software company. Avalon GloboCare Rebrands As Change Agents The company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol CHGA on July 22, 2026. The name change, ticker change and existing CUSIP number will not affect shareholders’ ownership interests. Shareholders do not need to take any
Company to begin trading tomorrow under new Nasdaq ticker symbol CHGA as it advances its portfolio of agentic AI software platforms, including Beacon and Catch-Up Company is actively evaluating additional AI software opportunities in other sectors such as defense and security FREEHOLD, N.J., July 21, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of agentic artificial intelligence ("AI") software solutions, today announced its strategic tr
Detailed price information for Avalon Globocare (ALBT-Q) from The Globe and Mail including charting and trades.
Investors talking about ALBT also mention
What share of all stock conversation is about ALBT?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% +0 | 0% 0 |
Of the messages about ALBT that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 0% | 0% | 86.35% -0.07 | ||
| Bearish | — | 100% | 100% | 13.65% +0.07 |
Of the messages about ALBT that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 95.24% | 53.82% | ||
| Technical Analysis | — | 0% | 0% | 43.23% | ||
| Controversies | — | 0% | 4.76% | 0.86% | ||
| Macro | — | 0% | 0% | 1.35% | ||
| Analysts | — | 0% | 0% | 0% | ||
| Earnings | — | 0% | 0% | 0.74% |
Of the messages about ALBT, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 53.33% | 57.45% | 27.4% | ||
| Newcomers | — | 46.67% | 42.55% | 72.6% |